Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
315 Leser
Artikel bewerten:
(0)

BioEconomy Investor Will be Hosting Gevo, Inc.'s CEO, Dr. Patrick Gruber on January 18th, 2018 as Part of the alphaDIRECT BioEconomy Investor Virtual Conference Series

SAN FRANCISCO, CA / ACCESSWIRE / January 16, 2018 / alphaDIRECT BioEconomy Investor, a research and Investor Intelligence firm, announced today that Dr. Patrick Gruber, Chief Executive Officer of Gevo, Inc. (NASDAQ: GEVO), will participate in the alphaDIRECT BioEconomy Investor Virtual Conference Series on Thursday, January 18th, 2018 at 11:00 AM PST/ 2:00 PM EST.

Gevo is a leading renewable technology, chemical products, and next generation biofuels company. Gevo has developed proprietary technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to focus primarily on the production of isobutanol, as well as related products from renewable feedstocks.

Investors interested in participating in the event must register using the link below. Please note that registration for the live event is limited but may be accessed at any time for replay after the presentation ends on January 18th, 2018.

Registration Link: https://pgi.webcasts.com/starthere.jsp?ei=1178365&tp_key=85b6c0a4ca

About alphaDIRECT BioEconomy Investor

alphaDIRECT BioEconomy Investor (BEI), a division of alphaDIRECT Advisors, is a research and Investor Intelligence firm that creates and implements digital content and programs to help investors better understand a company's key drivers including industry dynamics, technology, strategy, outlook, and risks as well as the impact they could have on the stock price. BEI's expertise encompasses a variety of sectors including Chemicals and Materials, Fuels, Nutrition, AgTech, Raw Materials, Bioconversion and Manufacturing and Genetics and Genomics. BEI was founded by Wall Street veteran and research analyst, Shawn Severson, after seeing a significant shift in the investment industry that resulted in less fundamental research conducted on small cap companies and a significant decline in information available to all investors. BEI's mission is to bridge that information gap and engage companies and investors in a way that opens information flow and analytical insights.

To receive complimentary news and updates from alphaDIRECT BioEconomy Investor, please visit: www.bioeconomyinvestor.com.

Sign up to follow alphaDIRECT BioEconomy Investor at: https://twitter.com/BEI_AlphaDirect.

Contact:

alphaDIRECT Advisors
BioEconomy Investor
Shawn M. Severson
+1 415-233-7094
shawn@bioeconomyinvestor.com
@BEI_AlphaDirect
www.bioeconomyinvestor.com

SOURCE: BioEconomy Investor

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2018 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.